Cenduit introduces clinical trial supply simulation and forecasting service
Helps minimise under- or over-supply of drugs
Cenduit, a provider of clinical trials interactive response technology (IRT), has introduced a study simulation and forecasting service that will enable clinical trial sites to plan and control supplies for their patients better. When integrated with Cenduit’s IRT services, the new service will give sponsors complete confidence in their clinical supply chain, the Durham, NC, US-based company says.
‘Clinical trials are more complex than ever and a robust and reliable clinical trial supply strategy is vital to study success,’ said Jogin Desai, CEO of Cenduit.
‘The simulation and forecasting models, integrated with the patient randomisation and drug allocation services inherent in our IRT systems, allow the complete coordination of procurement, packaging and logistics, with supply requirements from the sites themselves continuously factored in.’
Desai said the new system helps minimise the risk of drug over- or under-supply at sites and accelerates drug development through increased supply chain efficiency. The system also allows clinical trial supply coordinators to test different supply scenarios before implementing them, and to identify in advance the risks associated with any supply strategy.
‘By integrating forecasting and simulation parameters into the IRT system, patients will receive the right treatment on time, every time and at the lowest cost,’ Desai said.
